For more info, visit: https://www.primrmed.com/cancer-clinical-trials/stampede2
The METANOVA trial investigates treating oligometastatic prostate cancer with metastasis-directed radiotherapy (MDRT) in addition to standard systemic and prostate-directed therapy.
MDRT, using targeted radiation on all metastatic sites, aims to extend the time until cancer returns and potentially improve patient survival.
#cancer #oncology #prostatecancer #oligomets #oligometastatic #metastaticprostatecancer #hormonetherapy #systemictherapy #radiation #radiationtherapy #RT #MDRT #clinicalresearch #clinicaltrials #video #digital #health #menshealth #womenshealth #PRIMR